Le Lézard
Classified in: Health, Covid-19 virus

Viral Solutions partners with Georgia Department of Public Health to open three COVID-19 PCR Testing Center SuperSites in Atlanta


ATLANTA, Jan. 16, 2022 /PRNewswire-PRWeb/ -- As part of Georgia Governor Brian Kemp's initiative to increase the availability and access to efficient COVID-19 PCR testing, Viral Solutions has been chosen by the Georgia Department of Public Health (GaDPH) to spearhead an effort to rapidly open three COVID-19 PCR Testing Center SuperSites throughout the Atlanta Metro area.

Viral Solutions will continue to perform PCR COVID-19 testing with no out-of-pocket cost to insured and non-insured patients. Register for Covid testing here.

"We are proud to partner with GaDPH to continue to deliver fast and reliable drive-through COVID-19 testing at these three new SuperSites," says Viral Solutions co-founder and CEO, Ben Lefkove, MD. "We are prepared to help Atlanta get through this pandemic, and help the community stay safe so they can live their lives."

The three drive-through COVID-19 PCR Testing SuperSites are located conveniently throughout the Metro Atlanta area, and are appointment-only:

"As the largest provider of COVID-19 testing and vaccinations in Georgia, we are thrilled to bring our efficient PCR COVID-19 testing model to these new GaDPH SuperSites," says Viral Solutions co-founder and President, Ron Sanders, PA-C. "We are honored to partner with the Georgia Department of Public Health. It's important initiatives like this that drive us to do even more and get better every day."

In addition to the three new SuperSites, Viral Solutions offers no appointment needed, no out-of-pocket cost, all insurance accepted, drive-through COVID-19 testing at 18 other sites in Atlanta and throughout Georgia. Patients are evaluated in real time by Viral Solutions physicians and physician assistants. Viral Solutions is the largest and most efficient COVID-19 testing and vaccination provider in Georgia. Learn more at ViralSolutionsGA.com.

Interviews available upon request.

About Viral Solutions

Viral Solutions was founded by an Atlanta-based emergency physician and physician assistant to help find a way to resolve the current COVID-19 PCR testing crisis in Georgia. Patients are evaluated in real time by a local team of Viral Solutions physicians and physician assistants. Viral Solutions believes every person should have immediate access to the best COVID-19 testing available. No patient should wait to get a COVID-19 test. All patients ? including the uninsured ? should have easy access to COVID-19 testing, and that's what Viral Solutions provides.

Media Contact

Jon Waterhouse, Lenz, Inc., +1 404.721.3983, [email protected]

 

SOURCE Viral Solutions


These press releases may also interest you

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...

at 04:31
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...



News published on and distributed by: